The Global Insulin Pens Market was valued at US$ 650.4 million in 2021 and is expected to reach US$ 1,678.4 million by 2031. The market is projected to register a CAGR of 10.2% from 2023 to 2031, driven by the increasing prevalence of diabetes, growing demand for convenient insulin administration, and continued development of advanced drug-delivery technologies....